Angiotensin-converting enzyme gene polymorphism and cardiovascular endocrine system in coronary angiography patients

Japanese Heart Journal

Volumn 38, Issue 6, 1997, Pages 799-810

  Tsukada, Kohju ^a   Ishimitsu, Toshihiko ^a   Tsuchiya, Noriaki ^a   Horinaka, Shigeo ^a   Matsuoka, Hiroaki ^a  

^a DOKKYO MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiotensin converting enzyme; Atrial natriuretic peptide; Coronary artery disease; Gene polymorphism; Left ventricular mass

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ATRIAL NATRIURETIC FACTOR; CATECHOLAMINE; DIPEPTIDYL CARBOXYPEPTIDASE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ANGIOCARDIOGRAPHY; ARTICLE; CATECHOLAMINE BLOOD LEVEL; DNA POLYMORPHISM; ENDOCRINE SYSTEM; ETHNIC GROUP; FEMALE; GENOTYPE; HEART CATHETERIZATION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK;

EID: 0031467817     PISSN: 00214868     EISSN: None     Source Type: Journal    
DOI: 10.1536/ihj.38.799     Document Type: Article

References (42)

1. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene account for half of the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-6.
2. Schunkert H, Hense H-W, Holmer SR, et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy. N Engl J Med 1994; 330: 1634-8.
3. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M. DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 1994; 90: 2622-8.
4. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 1992; 359: 641-4.
5. Ruiz J, Blanche H, Cohen N, Insertion/deletion polymorphism of the angiotensin-converting enzyme gene is strongly associated with coronary heart disease in non-insulin dependent diabetes mellitus. Proc Natl Acad Sci USA 1994; 91: 3662-5.
6. Arbustini E, Grasso M, Fasani R, et al. Angiotensin converting enzyme gene deletion allele is independently and strongly associated with coronary atherosclerosis and myocardial infarction. Br Heart J 1995; 74: 584-94.
7. Beohar N, Damaraju S, Prather A, et al. Angiotensin I-converting enzyme genotype DD is a risk factor for coronary artery disease. J Invest Med 1995; 43: 275-80.
8. Bohn M, Berge KE, Bakken A, Erikssen J, Berg K. Insertion/deletion (I/D) polymorphism at the locus for angiotensin I-converting enzyme and myocardial infarction. Clin Genet 1993; 44: 292-7.
9. Lindpaintner K, Pfeffer MA, Kreutz R, et al. A prospective evaluation of an angiotensin-converting enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-11.
10. Friedl W, Krempler F, Paulweber B, Pichler M, Sandhofer F. A deletion polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Australian population. Atherosclerosis 1995; 112: 137-43.
11. Katsuya T, Koike G, Yee TW, Sharpe N, Jackson R, Norton R, et al. Association of angiotensinogen gene T235 variant with increased risk of coronary heart disease. Lancet 1995; 345: 1600-3.
12. Winkelmann BR, Nauck M, Klein B, et al. Deletion polymorphism of the angiotensin I-converting enzyme gene is associated with increased plasma angiotensin-converting enzyme activity but not with increased risk for myocardial infarction and coronary artery disease. Ann Intern Med 1996; 125: 19-25.
13. Grossman W, Baim DS. Cardiac catheterization, angiography, and intervention (fourth edition). Philadelphia, Lea & Febiger, 1991.
14. Rigat B, Hubert C, Corvol P, Soubrier F. PCR detection of the insertion/deletion polymorphism of the human angiotensin converting enzyme gene (DCP1) (dipeptidylcarboxypeptidase 1). Nucleic Acids Res 1992; 20: 1433.
15. Shanmugam V, Sell KW, Saha BK. Mistyping ACE heterozygotes. PCR Methods Appl 1993; 3: 120-1.
16. Kasahara Y, Ashihara Y. Colorimetry of angiotensin-I converting enzyme activity in serum. Clin Chem 1981; 27: 1922-5.
17. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide (BNP) in comparison with those of A-type natriuretic peptide (ANP) in normal subjects and patients with heart failure. Circulation 1994; 90: 195-203.
18. Wynne J, Green LH, Mann T, Levin D, Grossman W. Estimation of left ventricular volumes in man from biplane cineangiograms filmed in oblique projections. Am J Cardiol 1978; 41: 726-32.
19. Devereaux B, Reichek N. Echocardiographic determination of left ventricular mass in man. Circulation 1977; 55: 613-8.
20. Tiret L, Rigat B, Visvikis S, et al. Evidence from combined segregation and linkage analysis that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels. Am J Hum Genet 1992; 51: 197-205.
21. Harrap SB, Davidson HR, Connor EM, et al. The angiotensin converting enzyme gene and predisposition to high blood pressure. Hypertension 1993; 21: 455 -60.
22. Lachurié M-L, Azizi M, Guyene TT, Alhenc-Gelas F, Ménard J. Angiotensin-converting enzyme gene polymorphism has no influence on the circulating renin-angiotensin-aldosterone system or blood pressure in normotensive subjects. Circulation 1995; 91: 2933-42.
23. Urata H, Kinoshita A, Misono KS, Bumpus M, Husain A. Identification of a highly specific chymase as the major angiotensin II-forming enzyme in human heart. J Biol Chem 1990; 265: 22348-57.
24. Okamura T, Okumshi H, Ayaziki K, Toda N. Conversion of angiotensin I to angiotensin II in dog isolated renal artery: role of two different angiotensin II-generating enzymes. J Cardiovasc Pharmacol 1990; 15: 353 9.
25. Baker KM, Aceto JF. Angiotensin II stimulation of protein synthesis and cell growth in chick cells. Am J Physiol 1990; 259: H610-8.
26. Itoh H, Mukoyama M, Pratt RE, Gibbons GH, Dzau VJ. Multiple autocrine growth factors modulate smooth muscle cell growth response to angiotensin II. J Clin Invest 1993; 91: 2268-74.
27. Schmieder RE, Messerli FH, Garavaglia GE, Nunez B, MacPhee AA, Re RN. Does the renin-angiotensin-aldosterone system modify cardiac structure and function in essential hypertension? Am J Med 1988; 84 (Suppl 3A): 136-9.
28. Harrap SB, Dominiczak AF, Fraser R, et al. Plasma angiotensin II, predisposition to hypertension, and left ventricular size in healthy young adults.
29. Jan Danser AH, Schalekamp MADH, Bax WA, et al. ACE in the human heart: effect of the deletion/ insertion polymorphism. Circulation 1995; 92: 1387-8.
30. Dahlöf B, Pennert K, Hansson L. Reversal of left ventricular hypertrophy in hypertensive patients: a metaanalysis of 109 treatment studies. Am J Hypertens 1992; 5: 95-110.
31. Farhy RD, Ho K-L, Carretero OA, Scicli AG. Kinins mediate the antiproliferative effect of ramipril in rat carotid artery. Biochem Biophys Res Commun 1992; 182: 283-8.
32. Linz W, Wiemer G, Schölkens BA. Bradykinin prevents left ventricular hypertrophy in rats. J Hypertens 1993; 11 (Suppl 5): S96-7.
33. Evans AE, Poirier O, Kee F, et al. Polymorphism of angiotensin-converting-enzyme gene in subjects who die from coronary heart disease. QJM 1994; 87: 211-4.
34. Cohn JN, Levine TB, Olivari MT, et al. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984; 311: 819-23.
35. Packer M, Lee WH, Kessler PD, Gottlieb SS, Bernstein JL, Kukin ML. Role of neurohumoral mechanisms in determining survival in patients with severe chronic heart failure. Circulation 1987; 75 (Suppl 4): 80-92.
36. Nishikimi T, Yoshihara F, Morimoto A, et al. Relationship between left ventricular geometry and natriuretic peptide levels in essential hypertension. Hypertension 1996; 28: 22-30.
37. Saito Y, Nakao K, Nishimura K, et al. Clinical application of atrial natriuretic polypeptide to patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 1987; 76: 115-24.
38. Yamada T, Horiuchi M, Morishita R, Zhang L, Pratt RE, Dzau VJ. In vivo identification of a negative regulatory element in the mouse renin gene using direct gene transfer. J Clin Invest 1995; 96: 1230-7.
39. Hunley TE, Julian BA, Phillips III JA, et al. Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996; 49: 571-7.
40. Ludwig E, Corneli PS, Anderson JL, Marshall HW, Lalouel J-M, Ward RH. Angiotensin-converting enzyme gene polymorphism is associated with myocardial infarction but not with development of coronary stenosis. Circulation 1995; 91: 2120-4.
41. Ohishi M, Fujii K, Minamino T, et al. A potent genetic risk factor for restenosis. Nat Genet 1993; 5: 1600-3.
42. Samani NJ, Martin DS, Brack M, et al. Insertion/deletion polymorphism in the angiotensin-converting enzyme gene and risk of restenosis after coronary angioplasty. Lancet 1995; 345: 1013-6.